Pharmacogenomics and IBD
- 1 February 2004
- journal article
- review article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 10, S35-S37
- https://doi.org/10.1097/00054725-200402001-00008
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Mutation in the ITPA gene predicts intolerance to azathioprineGastroenterology, 2003
- TPMT in the treatment of Crohn's disease with azathioprineGut, 2002
- Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapyGastroenterology, 2000
- Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's diseaseGastroenterology, 1999
- Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms*Clinical Pharmacology & Therapeutics, 1997
- Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine IntoleranceAnnals of Internal Medicine, 1997
- Azathioprine and 6-Mercaptopurine in Crohn DiseaseAnnals of Internal Medicine, 1995
- The clinical pharmacology of 6-mercaptopurineEuropean Journal of Clinical Pharmacology, 1992
- Azathioprine Metabolism: Pharmacokinetics of 6‐Mercaptopurine, 6‐Thiouric Acid and 6‐Thioguanine Nucleotides in Renal Transplant PatientsThe Journal of Clinical Pharmacology, 1990
- Childhood leukaemia: a relationship between intracellular 6‐ mercaptopurine metabolites and neutropenia.British Journal of Clinical Pharmacology, 1983